Daniel Brennan

Managing Director, Research, Health Care - Life Science & Diagnostic Tools

Headshot photo of Daniel Brennan

At Cowen, Dan is responsible for providing research coverage on a diverse group of companies across the Life Science & Diagnostics Tools’ industry. This includes identifying key investment debates, building financial models, generating research reports, including ‘Ahead of the Curve’ deep dive analysis, making stock recommendations and engaging with clients and Cowen representatives.

Daniel Brennan is a senior analyst covering Life Science & Diagnostic Tools. Prior to joining Cowen, Dan was a Managing Director and senior Life Science & Diagnostic Tools analyst at UBS. Prior to UBS, he was a senior health care analyst at Columbus Circle Investors. Dan also spent 19 years at Morgan Stanley, where he served, amongst other roles, as the health care sector equity sales specialist and later as the senior Life Science & Diagnostic Tools analyst.

Mr. Brennan holds a BA in economics from Georgetown University, and an MBA from Harvard University. He is also a CFA® charterholder.


Get In Touch

Start a conversation with Daniel Brennan


    Explore related thought leadership, reports, coverage and insights for Daniel Brennan.

    A view of a blood sample under a microscope
    Ahead of the Curve®

    MRD 2.0: Deep Dive Into The Coming Solid Tumor Opportunity

    A lightbulb planted in soil with a sprout growing from inside it representing our best ESG investment ideas for 2023.

    Best ESG Investment Ideas for 2023

    DNA configuration representing single cell spatialomics.
    Ahead of the Curve®

    Single Cell & Spatialomics: What Does The Future Hold?